In advanced BC, the positive expression rates of CCN5 and ER in invasive carcinoma were 39.22% (51/130) and 36.92% (48/130) respectively, while the negative expression rates were 60.77% (79/130) and 63.08% (82/130) respectively. This evidence concerns the gene CCN5 and breast cancer.